Evozyne
Designs engineered protein therapeutics using an AI-native platform.
aibiotech
Company facts
- Founded
- 2020
- Employees
- 70
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $81M · 2023
Open positions
1 job
8 views last week
Director/Senior Director, Preclinical Program Leadership
North AmericaSenior
United States
Chicago, ILEvozyne is an AI-native biotech company building a new way to design therapeutic proteins. Our generative AI platform was purpose-built to create entirely novel proteins that expand what’s possible beyond traditional…
AI Generative AI Performance Management